Cargando…
TGF-β1 Receptor Inhibitor SB525334 Attenuates the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells via the TGF-β1 Signaling Pathway
We investigated the effect of SB525334 (TGF-β receptor type 1 (TβRI) inhibitor) on the epithelial to mesenchymal transition (EMT) signaling pathway in human peritoneal mesothelial cells (HPMCs) and a peritoneal fibrosis mouse model. In vitro experiments were performed using HPMCs. HPMCs were treated...
Autores principales: | Heo, Jung-Yoon, Do, Jun-Young, Lho, Yunmee, Kim, A-Young, Kim, Sang-Woon, Kang, Seok-Hui |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8301792/ https://www.ncbi.nlm.nih.gov/pubmed/34356903 http://dx.doi.org/10.3390/biomedicines9070839 |
Ejemplares similares
-
Effects of TGF-β1 Receptor Inhibitor GW788388 on the Epithelial to Mesenchymal Transition of Peritoneal Mesothelial Cells
por: Lho, Yunmee, et al.
Publicado: (2021) -
Elabela Attenuates the TGF-β1-Induced Epithelial-Mesenchymal Transition of Peritoneal Mesothelial Cells in Patients Receiving Peritoneal Dialysis
por: Xie, Shunyun, et al.
Publicado: (2022) -
Reprogramming of Mesothelial-Mesenchymal Transition in Chronic Peritoneal Diseases by Estrogen Receptor Modulation and TGF-β1 Inhibition
por: Wilson, Robert B., et al.
Publicado: (2020) -
Effect of TGF-β(1) Stimulation on the Smad Signal Transduction Pathway of Human Peritoneal Mesothelial Cells
por: Zhang, Hao, et al.
Publicado: (2005) -
TGF-β1 induces peritoneal fibrosis by activating the Smad2 pathway in mesothelial cells and promotes peritoneal carcinomatosis
por: Lv, Zhi-Dong, et al.
Publicado: (2023)